Michel Gréco

From 1987 to 1993, through successive mergers and acquisitions, I had senior management responsibilities at Institut Mérieux, then Pasteur Mérieux Connaught. From 1994 to 1998, I was President and CEO of Pasteur Mérieux MSD (a European joint venture between Pasteur Mérieux and Merck). Since 1998 and until the beginning of 2003, I was President and COO, then Deputy CEO and member of the Board of Aventis Pasteur.

During my years in Vaccines, I was also involved in Industry Organizations. I was President of the European Vaccine manufacturers (EVM) between 1994 and 1998. From 1999 to 2002, I was Chairman of the Biological Committee of IFPMA (International Federation of Pharmaceutical Manufacturers Associations) and a member of the SAGE (Strategic Advisory Group of Experts), which advises WHO on Immunization policy.
I was also a member of the Board of the French Pharma Association and the President of its European Affairs Commission.

I am presently member of the Boards of several biotechnology companies on both sides of the Atlantic (including being chairman of the Board of Intercell AG in Austria and of Glycovaxyn in Switzerland) and of non profit international institutions.

I have communicated in various Industry meetings over the years, published several articles on the Vaccine Industry, and recently contributed a chapter for the fourth edition of "New Generation Vaccines".